Chromatin Regulation / Acetylation
HP1α Blocking Peptide
|
イイネ!(0)
|
|
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報  カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #1004S | 100 μg | 16,000 | |
|
HP1alpha抗体製品一覧
| 使用目的 | |
| HP1α Antibody (#2616) およびHP1α (C7F11) Rabbit mAb (#2623) の反応をブロックし、抗体の特異性を確認するために使用 |
IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma using HP1α (C7F11) Rabbit mAb #2623 in the presence of control peptide (left) or HP1α Blocking Peptide (right).
Heterochromatin protein 1 (HP1) is a family of heterochromatic adaptor molecules involved in both gene silencing and higher order chromatin structure (1). All three HP1 family members (α, β and γ) are primarily associated with centromeric heterochromatin; however, HP1β and γ also localize to euchromatic sites in the genome (2,3). HP1 proteins are approximately 25 kDa in size and each contains a conserved amino-terminal chromodomain, followed by a variable hinge region and a conserved carboxy-terminal chromoshadow domain. The chromodomain facilitates binding to histone H3 tri-methylated on Lys9, a histone "mark" closely associated with centromeric heterochromatin (4,5). The variable hinge region binds both RNA and DNA in a sequence-independent manner (6). The chromoshadow domain mediates the dimerization of HP1 proteins, in addition to binding multiple proteins implicated in gene silencing and heterochromatin formation, including the SUV39H histone methyltransferase, the DNMT1 and DNMT3a DNA methyltransferases and the p150 subunit of chromatin-assembly factor-1 (CAF1) (7-9). In addition to contributing to heterochromatin formation and propagation, HP1 and SUV39H are also found complexed with retinoblastoma (Rb) and E2F6 proteins, both of which function to repress euchromatic gene transcription in quiescent cells (10,11). HP1 proteins are subject to multiple types of post-translational modifications, including phosphorylation, acetylation, methylation, ubiquitination and sumoylation, suggesting multiple means of regulation (12-14).
-
Maison, C. and Almouzni, G. (2004) Nat. Rev. Mol. Cell Biol. 5, 296-304.
-
Minc, E. et al. (2000) Cytogenet. Cell Genet. 90, 279-284.
-
Nielsen, A.L. et al. (2001) Mol. Cell 7, 729-739.
-
Lachner, M. et al. (2001) Nature 410, 116-120.
-
Bannister, A.J. et al. (2001) Nature 410, 120-124.
-
Muchardt, C. et al. (2002) EMBO Rep. 3, 975-981.
-
Yamamoto, K. and Sonoda, M. (2003) Biochem. Biophys. Res. Commun. 301, 287-292.
-
Fuks, F. et al. (2003) Nucleic Acids Res. 31, 2305-2312.
-
Murzina, N. et al. (1999) Mol. Cell 4, 529-540.
-
Nielsen, S.J. et al. (2001) Nature 412, 561-565.
-
Ogawa, H. et al. (2002) Science 296, 1132-1136.
-
Minc, E. et al. (1999) Chromosoma 108, 220-234.
-
Zhao, T. et al. (2001) J. Biol. Chem. 276, 9512-9518.
-
Lomberk, G. et al. (2006) Nat. Cell Biol. 8, 407-415.